Redbud Blogs
Barriers to sequencing for everyday diagnostics
If it wasn’t clear before COVID-19, it is now: ubiquitous, worldwide testing for infectious diseases is crucial for public health and prosperity. Nucleic acid amplification tests (NAATs) are the gold standard for infectious disease diagnosis.
High-performance sample prep on-cartridge
Any developer of a sample-to-answer device knows that getting sample prep working on-cartridge is a major source of risk. It makes matters worse that issues with sample prep usually arise late in the development process. Sample prep is often responsible when product...
The state of safely reopening amid COVID-19
The SARS-CoV-2 virus brings much risk, but a good workplace-return-to-facility plan that takes account of how the virus spreads can make a huge difference in mitigating outbreak risk. And hopefully, such a plan can ease feelings of worker uncertainty. Well, at least until we solve the longer-term challenges of unleashing a SAR-CoV-2 vaccine and the point-of-need tests our industry’s intent is to resolve ASAP.
400 Park Offices Dr.
Suite 301
RTP NC 27709
In The News
Redbud Labs to exhibit and present poster at APHL ID Lab Con 2025
Redbud Labs is exhibiting at APHL ID Lab Con ’25, Booth #610 and presenting a poster in collaboration with the Wadsworth Center.